As the global economy mends, the 2021 growth of Antipyretic and Analgesic Raw Materials will have significant change from previous year. According to our (LP Information) latest study, the global Antipyretic and Analgesic Raw Materials market size is USD million in 2022 from USD 2652.5 million in 2021, with a change of % between 2021 and 2022. The global Antipyretic and Analgesic Raw Materials market size will reach USD 2993.5 million in 2028, growing at a CAGR of 1.7% over the analysis period 2022-2028.
The United States Antipyretic and Analgesic Raw Materials market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Antipyretic and Analgesic Raw Materials market, reaching US$ million by the year 2028. As for the Europe Antipyretic and Analgesic Raw Materials landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Antipyretic and Analgesic Raw Materials players cover SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED, Mallinckrodt Pharmaceuticals, IOL, and Anqiu Lu'an Pharmaceutical Co., Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic and Analgesic Raw Materials market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxapzin
Dexibuprofen
Anagen
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Adult
Child
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu'an Pharmaceutical Co., Ltd.
Basf
Novacyl
BBCA Pharmaceutical
Hubei Biocause Phamaceutical Co., Ltd.
Changshu Huagang Pharmaceutical Co., Ltd
Granules India Limited
Hebei Jiheng pharmaceutical Co., Ltd
Kangle Pharmaceutical CO., LTD
Hebei Jingye Medical Technology Co., Ltd
Hunan Zhongnan Pharmaceutical Co., Ltd